Development of Accula Flu/SARS-CoV-2 Assay
Award Notice Posted
- Solicitation number
- 75A50121P00008
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Awarded
- to Mesa Biotech Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75A50121P00008 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- San Diego CA 92121 USA
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response announced the award of a contract to MESA BIOTECH, INC. to develop an Accula Flu/SARS-CoV-2 assay for $12,991,595.11. The contract was awarded under a class justification and approval that permits contracting actions under unusual and compelling urgency to address the COVID-19 pandemic through February 2022 and acquire critically needed supplies, services, research and development support, equipment, information technology, and other items as response and recovery efforts evolve.
Notice text
This contract action was awarded under a class Justification & Approval (J&A) in accordance with FAR 6.302-2, Unusual and Compelling Urgency, to facilitate the recovery efforts necessary to address the 2019 Novel Coronavirus (COVID-19). This class J&A is essential to respond to urgent requests for immediate support to respond to the expanding outbreak of COVID-19 which was declared a global pandemic by the World Health Organization (WHO) on March 11, 2020 and a national emergency via a Presidential Proclamation on March 13, 2020.
The ultimate spread, length of time, and severity of the COVID-19 outbreak is unknown as this time and current data indicate that COVID-19 has begun to spread exponentially, in the typical pattern for an epidemic. This constitutes an unusual and compelling urgency that demands immediate attention. Immediate acquisition of services and supplies will help ensure that the United States of America remains prepared for and capable of responding to a public health emergency in the necessary and immediate manner that is required.
Awarded contract 75A50121P00008 to MESA BIOTECH, INC. for 12991595.11 on 2020-11-05.
Files
| File | Type | Posted |
|---|---|---|
| Class J and A Final 3.21.20 (Redacted).pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity